Stat3β mitigates development of atherosclerosis in apolipoprotein E-deficient mice

Journal of Molecular Medicine

Volumn 91, Issue 8, 2013, Pages 965-976

  Lee, Jihyun ^a,d   Baldwin III, William M ^b   Lee, Chih Yuan ^c   Desiderio, Stephen ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acute phase response; Atherosclerosis; Inflammation; Stat3

Indexed keywords

APOLIPOPROTEIN E; INTERLEUKIN 17; INTERLEUKIN 6; STAT3 BETA PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE EXACERBATION; FAT INTAKE; FEEDING; FEMALE; GENE EXPRESSION; GENOTYPE; LIPID DIET; LIPOPROTEIN DEFICIENCY; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHENOTYPE; SPLEEN CELL; TH17 CELL;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BODY WEIGHT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHOLESTEROL; CYTOKINES; DIET, HIGH-FAT; FEMALE; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, KNOCKOUT; STAT3 TRANSCRIPTION FACTOR; TRIGLYCERIDES;

EID: 84881239744     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-013-1013-5     Document Type: Article

References (53)

1. Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6:508-519 (Pubitemid 43980523)
2. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767-1772 (Pubitemid 30213096)
3. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB (1999) C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99:237-242 (Pubitemid 29056365)
4. Speidl WS, Graf S, Hornykewycz S, Nikfardjam M, Niessner A, Zorn G, Wojta J, Huber K (2002) High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease. Am Heart J 144:449-455
5. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843 (Pubitemid 30165206)
6. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J (1998) Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351:88-92 (Pubitemid 28026634)
7. Schonbeck U, Varo N, Libby P, Buring J, Ridker PM (2001) Soluble CD40L and cardiovascular risk in women. Circulation 104:2266-2268 (Pubitemid 33049505)
8. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, Linton MF, Raggi P, Stein CM (2003) Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 349:2407-2415 (Pubitemid 37542989)
9. Riikola A, Sipila K, Kahonen M, Jula A, Nieminen MS, Moilanen L, Kesaniemi YA, Lehtimaki T, Hulkkonen J (2009) Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey. Atherosclerosis 207:466-470
10. Blankenberg S, Barbaux S, Tiret L (2003) Adhesion molecules and atherosclerosis. Atherosclerosis 170:191-203 (Pubitemid 37377790)
11. Breslow JL (1996) Mouse models of atherosclerosis. Science 272:685-688 (Pubitemid 26000273)
12. Moore KJ, Tabas I (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145:341-355
13. Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, Means T, Halmen K, Luster AD, Golenbock DT et al (2004) Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 10:416-421 (Pubitemid 38508522)
14. Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M (2003) Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 23:656-660 (Pubitemid 36438080)
15. Desiderio S, Yoo JY (2003) A genome-wide analysis of the acute-phase response and its regulation by Stat3beta. Ann N Y Acad Sci 987:280-284 (Pubitemid 36584036)
16. Caldenhoven E, van Dijk TB, Solari R, Armstrong J, Raaijmakers JA, Lammers JW, Koenderman L, de Groot RP (1996) STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem 271:13221-13227 (Pubitemid 26175904)
17. Schaefer TS, Sanders LK, Nathans D (1995) Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. Proc Natl Acad Sci U S A 92:9097-9101
18. Yoo JY, Huso DL, Nathans D, Desiderio S (2002) Specific ablation of Stat3beta distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock. Cell 108:331-344 (Pubitemid 34178398)
19. Schaefer TS, Sanders LK, Park OK, Nathans D (1997) Functional differences between Stat3alpha and Stat3beta. Mol Cell Biol 17:5307-5316
20. Ray JL, Leach R, Herbert JM, Benson M (2001) Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci 23:185-188 (Pubitemid 34863290)
21. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14:133-140
22. Reddick RL, Zhang SH, Maeda N (1994) Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 14:141-147
23. Tangirala RK, Rubin EM, Palinski W (1995) Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 36:2320-2328
24. Ma Y, Wang W, Zhang J, Lu Y, Wu W, Yan H, Wang Y (2012) Hyperlipidemia and atherosclerotic lesion development in LDLR-deficient mice on a long-term high-fat diet. PLoS One 7:e35835
25. Caligiuri G, Nicoletti A, Zhou X, Tornberg I, Hansson GK (1999) Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis 145:301-308 (Pubitemid 29359138)
26. Lesina M, Kurkowski MU, Ludes K, Rose-John S, Treiber M, Kloppel G, Yoshimura A, Reindl W, Sipos B, Akira S et al (2011) Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 19:456-469
27. Kraal G, Rep M, Janse M (1987) Macrophages in T and B cell compartments and other tissue macrophages recognized by monoclonal antibody MOMA-2. An immunohistochemical study. Scand J Immunol 26:653-661
28. Austyn JM, Gordon S (1981) F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11:805-815 (Pubitemid 12237981)
29. Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485-517
30. Gao Q, Jiang Y, Ma T, Zhu F, Gao F, Zhang P, Guo C, Wang Q, Wang X, Ma C et al (2010) A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J Immunol 185:5820-5827
31. Smith E, Prasad KM, Butcher M, Dobrian A, Kolls JK, Ley K, Galkina E (2010) Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 121:1746-1755
32. Durant L, Watford WT, Ramos HL, Laurence A, Vahedi G, Wei L, Takahashi H, Sun HW, Kanno Y, Powrie F et al (2010) Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 32:605-615
33. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR (2007) IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8:967-974 (Pubitemid 47300011)
34. Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, Shah B, Chang SH, Schluns KS, Watowich SS et al (2008) Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29:44-56
35. Avagyan S, Aguilo F, Kamezaki K, Snoeck HW (2011) Quantitative trait mapping reveals a regulatory axis involving peroxisome proliferator-activated receptors, PRDM16, transforming growth factor-beta2 and FLT3 in hematopoiesis. Blood 118:6078-6086
36. Chang X, Gao JX, Jiang Q, Wen J, Seifers N, Su L, Godfrey VL, Zuo T, Zheng P, Liu Y (2005) The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J Exp Med 202:1141-1151 (Pubitemid 41464507)
37. Maritano D, Sugrue ML, Tininini S, Dewilde S, Strobl B, Fu X, Murray-Tait V, Chiarle R, Poli V (2004) The STAT3 isoforms alpha and beta have unique and specific functions. Nat Immunol 5:401-409 (Pubitemid 38500089)
38. Bates SH, Stearns WH, Dundon TA, Schubert M, Tso AW, Wang Y, Banks AS, Lavery HJ, Haq AK, Maratos-Flier E et al (2003) STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421:856-859 (Pubitemid 36254146)
39. Cernkovich ER, Deng J, Bond MC, Combs TP, Harp JB (2008) Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity. Endocrinology 149:1581-1590 (Pubitemid 351468313)
40. Lyngdorf LG, Gregersen S, Daugherty A, Falk E (2003) Paradoxical reduction of atherosclerosis in apoE-deficient mice with obesity-related type 2 diabetes. Cardiovasc Res 59:854-862 (Pubitemid 38366241)
41. Chiba T, Shinozaki S, Nakazawa T, Kawakami A, Ai M, Kaneko E, Kitagawa M, Kondo K, Chait A, Shimokado K (2008) Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice. Atherosclerosis 196:68-75
42. Austin MA (1989) Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. Am J Epidemiol 129:249-259 (Pubitemid 19046992)
43. Gotto AM Jr (1998) Triglyceride as a risk factor for coronary artery disease. Am J Cardiol 82:22Q-25Q (Pubitemid 128712604)
44. Zadelaar S, Kleemann R, Verschuren L, de Vries-Van, der Weij J, van der Hoorn J, Princen HM, Kooistra T (2007) Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 27:1706-1721 (Pubitemid 47207165)
45. -/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am J Pathol 168:649-658 (Pubitemid 43271162)
46. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121-1133 (Pubitemid 44380299)
47. Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E, Hipkiss EL, Getnet D, Goldberg MV, Maris CH et al (2007) Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol 179:4313-4317
48. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, Dong C (2007) STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282:9358-9363 (Pubitemid 47104613)
49. Erbel C, Chen L, Bea F, Wangler S, Celik S, Lasitschka F, Wang Y, Bockler D, Katus HA, Dengler TJ (2009) Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J Immunol 183:8167-8175
50. van Es T, van Puijvelde GH, Ramos OH, Segers FM, Joosten LA, van den Berg WB, Michon IM, de Vos P, van Berkel TJ, Kuiper J (2009) Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem Biophys Res Commun 388:261-265
51. Butcher MJ, Gjurich BN, Phillips T, Galkina EV (2012) The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment. Circ Res 110:675-687
52. Taleb S, Romain M, Ramkhelawon B, Uyttenhove C, Pasterkamp G, Herbin O, Esposito B, Perez N, Yasukawa H, Van Snick J et al (2009) Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med 206:2067-2077
53. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C et al (1999) Protective role of interleukin-10 in atherosclerosis. Circ Res 85:e17-e24